Blueprint Medicines (BPMC) PT Raised to $125 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein raised the price target on Blueprint Medicines (NASDAQ: BPMC) to $125.00 (from $85.00) while maintaining a Buy rating.
You May Also Be Interested In
- RBC Capital Downgrades Bapcor Ltd. (BAP:AU) to Underperform
- Goldman Sachs Downgrades Mitsubishi Gas Chemical Co Inc (4182:JP) to Neutral
- Freedom Broker Downgrades STRATTEC Security (STRT) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
